Free Trial

Bowman & Co S.C. Acquires New Shares in Synopsys, Inc. (NASDAQ:SNPS)

Synopsys logo with Computer and Technology background

Bowman & Co S.C. purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 688 shares of the semiconductor company's stock, valued at approximately $334,000.

Several other institutional investors and hedge funds also recently made changes to their positions in SNPS. Davidson Capital Management Inc. increased its holdings in Synopsys by 33,828.6% in the third quarter. Davidson Capital Management Inc. now owns 4,750 shares of the semiconductor company's stock worth $2,405,000 after purchasing an additional 4,736 shares in the last quarter. Peloton Wealth Strategists increased its holdings in Synopsys by 221.2% in the third quarter. Peloton Wealth Strategists now owns 2,881 shares of the semiconductor company's stock worth $1,459,000 after purchasing an additional 1,984 shares in the last quarter. Swiss National Bank increased its holdings in Synopsys by 0.7% in the third quarter. Swiss National Bank now owns 454,800 shares of the semiconductor company's stock worth $230,306,000 after purchasing an additional 3,200 shares in the last quarter. Parnassus Investments LLC bought a new stake in Synopsys in the third quarter worth approximately $633,469,000. Finally, Harvest Portfolios Group Inc. increased its holdings in Synopsys by 3.7% in the third quarter. Harvest Portfolios Group Inc. now owns 42,121 shares of the semiconductor company's stock worth $21,330,000 after purchasing an additional 1,496 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Stock Up 2.1 %

SNPS stock traded up $10.89 during midday trading on Friday, hitting $526.70. The company's stock had a trading volume of 1,240,502 shares, compared to its average volume of 870,192. The stock's 50-day moving average price is $519.43 and its 200 day moving average price is $525.54. Synopsys, Inc. has a 1 year low of $457.52 and a 1 year high of $629.38. The stock has a market cap of $81.42 billion, a price-to-earnings ratio of 36.27, a PEG ratio of 3.22 and a beta of 1.12.

Insiders Place Their Bets

In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the business's stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares of the company's stock, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.66% of the company's stock.

Analysts Set New Price Targets

SNPS has been the subject of several recent research reports. Redburn Atlantic initiated coverage on Synopsys in a report on Monday, January 13th. They set a "buy" rating and a $600.00 price objective for the company. Berenberg Bank initiated coverage on Synopsys in a report on Tuesday, October 15th. They set a "buy" rating and a $660.00 price objective for the company. Mizuho initiated coverage on Synopsys in a report on Tuesday, October 22nd. They set an "outperform" rating and a $650.00 price objective for the company. Rosenblatt Securities restated a "buy" rating and set a $635.00 price objective on shares of Synopsys in a report on Wednesday, December 4th. Finally, Robert W. Baird decreased their price objective on Synopsys from $644.00 to $630.00 and set an "outperform" rating for the company in a report on Thursday, December 5th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $641.82.

Get Our Latest Research Report on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Curious about the future of quantum computing? Rigetti Computing (NASDAQ: RGTI) has been making waves with its groundbreaking advances in quantum technology.

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines